Summary
Thermo Fisher Scientific Inc. reported solid financial results for the first quarter of 2017, demonstrating year-over-year growth in revenues and operating income. The company's total revenues increased by 11% to $4.77 billion, driven by strong performance across its business segments, particularly Life Sciences Solutions and Analytical Instruments, which saw significant contributions from recent acquisitions. This growth was complemented by ongoing demand in key end markets like pharmaceutical and biotech. Profitability also improved, with operating income rising 20% to $622 million, and the operating margin expanding to 13.1%. The company highlighted productivity gains and acquisition synergies as key drivers of this enhanced profitability, while also noting strategic growth investments. The company's liquidity remains strong, with sufficient cash flow from operations and available credit facilities to support its ongoing business needs and future growth initiatives. Overall, the report indicates a healthy financial position and positive operational momentum for Thermo Fisher Scientific.
Financial Highlights
56 data points| Revenue | $4.76B |
| Cost of Revenue | $2.13B |
| Gross Profit | $2.19B |
| R&D Expenses | $215.00M |
| SG&A Expenses | $1.33B |
| Operating Expenses | $4.14B |
| Operating Income | $620.00M |
| Interest Expense | $135.00M |
| Net Income | $551.00M |
| EPS (Basic) | $1.41 |
| EPS (Diluted) | $1.40 |
| Shares Outstanding (Basic) | 391.00M |
| Shares Outstanding (Diluted) | 394.00M |
Key Highlights
- 1Total revenues increased by 11% to $4.77 billion in Q1 2017 compared to $4.29 billion in Q1 2016.
- 2Operating income grew by 20% to $622 million in Q1 2017, with an improved operating margin of 13.1% compared to 12.1% in Q1 2016.
- 3Acquisitions contributed significantly to revenue growth, adding $346 million in the quarter.
- 4The Life Sciences Solutions and Analytical Instruments segments showed robust revenue growth of 12% and 39% respectively.
- 5Diluted Earnings Per Share (EPS) increased to $1.40 in Q1 2017 from $1.01 in Q1 2016.
- 6The company ended the quarter with strong liquidity, including $713 million in cash and cash equivalents, and sufficient operating cash flow and credit facilities to meet future needs.
- 7Thermo Fisher made strategic acquisitions in Q1 2017, including Core Informatics for $94 million and Finesse Solutions for $220 million, to enhance its informatics and bioproduction offerings.